These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8625367

  • 1. Preparation and functional evaluation of new doxorubicin immunoconjugates containing an acid-sensitive linker on small-cell lung cancer cells.
    Froesch BA, Stahel RA, Zangemeister-Wittke U.
    Cancer Immunol Immunother; 1996 Jan; 42(1):55-63. PubMed ID: 8625367
    [Abstract] [Full Text] [Related]

  • 2. Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.
    Trail PA, Willner D, Knipe J, Henderson AJ, Lasch SJ, Zoeckler ME, TrailSmith MD, Doyle TW, King HD, Casazza AM, Braslawsky GR, Brown J, Hofstead SJ, Greenfield RS, Firestone RA, Mosure K, Kadow KF, Yang MB, Hellström KE, Hellström I.
    Cancer Res; 1997 Jan 01; 57(1):100-5. PubMed ID: 8988048
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methods.
    Sinkule JA, Rosen ST, Radosevich JA.
    Tumour Biol; 1991 Jan 01; 12(4):198-206. PubMed ID: 1651554
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugates.
    King HD, Yurgaitis D, Willner D, Firestone RA, Yang MB, Lasch SJ, Hellström KE, Trail PA.
    Bioconjug Chem; 1999 Jan 01; 10(2):279-88. PubMed ID: 10077478
    [Abstract] [Full Text] [Related]

  • 5. Targeting of human squamous carcinomas by SPA470-doxorubicin immunoconjugates.
    Hebert C, Norris K, Sauk JJ.
    J Drug Target; 2003 Feb 01; 11(2):101-7. PubMed ID: 12881196
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes.
    Waibel R, Mannhart M, O'Hara CJ, Brocklehurst C, Zangemeister-Wittke U, Schenker T, Lehmann HP, Weber E, Stahel RA.
    Cancer Res; 1993 Jun 15; 53(12):2840-5. PubMed ID: 7684948
    [Abstract] [Full Text] [Related]

  • 7. Immunotoxins recognising a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer.
    Zangemeister-Wittke U, Collinson AR, Frösch B, Waibel R, Schenker T, Stahel RA.
    Br J Cancer; 1994 Jan 15; 69(1):32-9. PubMed ID: 7506925
    [Abstract] [Full Text] [Related]

  • 8. Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines.
    Elbayoumi TA, Torchilin VP.
    Eur J Pharm Sci; 2007 Nov 15; 32(3):159-68. PubMed ID: 17707615
    [Abstract] [Full Text] [Related]

  • 9. Determinants of differential doxorubicin sensitivity between SCLC and NSCLC.
    Singhal SS, Wickramarachchi D, Singhal J, Yadav S, Awasthi YC, Awasthi S.
    FEBS Lett; 2006 Apr 17; 580(9):2258-64. PubMed ID: 16579994
    [Abstract] [Full Text] [Related]

  • 10. Doxorubicin immunoconjugates containing bivalent, lysosomally-cleavable dipeptide linkages.
    Dubowchik GM, Radia S, Mastalerz H, Walker MA, Firestone RA, Dalton King H, Hofstead SJ, Willner D, Lasch SJ, Trail PA.
    Bioorg Med Chem Lett; 2002 Jun 03; 12(11):1529-32. PubMed ID: 12031335
    [Abstract] [Full Text] [Related]

  • 11. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
    Arabi L, Badiee A, Mosaffa F, Jaafari MR.
    J Control Release; 2015 Dec 28; 220(Pt A):275-286. PubMed ID: 26518722
    [Abstract] [Full Text] [Related]

  • 12. Anti-Sp17 monoclonal antibody-doxorubicin conjugates as molecularly targeted chemotherapy for ovarian carcinoma.
    Song JX, Li FQ, Cao WL, Jia X, Shi LN, Lu JF, Ma CF, Kong QQ.
    Target Oncol; 2014 Sep 28; 9(3):263-72. PubMed ID: 23943313
    [Abstract] [Full Text] [Related]

  • 13. (6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin.
    Willner D, Trail PA, Hofstead SJ, King HD, Lasch SJ, Braslawsky GR, Greenfield RS, Kaneko T, Firestone RA.
    Bioconjug Chem; 1993 Sep 28; 4(6):521-7. PubMed ID: 7508268
    [Abstract] [Full Text] [Related]

  • 14. Modulation of doxorubicin cytotoxicity by ethacrynic acid.
    Awasthi S, Singhal SS, He N, Chaubey M, Zimniak P, Srivastava SK, Singh SV, Awasthi YC.
    Int J Cancer; 1996 Nov 04; 68(3):333-9. PubMed ID: 8903475
    [Abstract] [Full Text] [Related]

  • 15. Disposition of conjugate-bound and free doxorubicin in tumor-bearing mice following administration of a BR96-doxorubicin immunoconjugate (BMS 182248).
    Mosure KW, Henderson AJ, Klunk LJ, Knipe JO.
    Cancer Chemother Pharmacol; 1997 Nov 04; 40(3):251-8. PubMed ID: 9219510
    [Abstract] [Full Text] [Related]

  • 16. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
    Zhou J, Chen J, Zhong R, Mokotoff M, Shultz LD, Ball ED.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2224-31. PubMed ID: 16609038
    [Abstract] [Full Text] [Related]

  • 17. Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity.
    Braslawsky GR, Kadow K, Knipe J, McGoff K, Edson M, Kaneko T, Greenfield RS.
    Cancer Immunol Immunother; 1991 Apr 01; 33(6):367-74. PubMed ID: 1878890
    [Abstract] [Full Text] [Related]

  • 18. Tumor targeting using anti-her2 immunoliposomes.
    Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks JD, Papahadjopoulos D, Benz CC.
    J Control Release; 2001 Jul 06; 74(1-3):95-113. PubMed ID: 11489487
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.
    Desrues B, Léna H, Brichory F, Ramée MP, Toujas L, Delaval P, Dazord L.
    Br J Cancer; 1995 Nov 06; 72(5):1076-82. PubMed ID: 7577450
    [Abstract] [Full Text] [Related]

  • 20. Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.
    Greenfield RS, Kaneko T, Daues A, Edson MA, Fitzgerald KA, Olech LJ, Grattan JA, Spitalny GL, Braslawsky GR.
    Cancer Res; 1990 Oct 15; 50(20):6600-7. PubMed ID: 2208122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.